tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts

3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Larimar Therapeutics (LRMR) – Larimar is a biotech company based in Pennsylvania that focuses on developing treatments for rare diseases, especially Friedreich’s ataxia, a genetic condition that affects movement and coordination. Today, Citizens JMP analyst Jonathan Wolleben reaffirmed his $18 price target on the stock. Furthermore, all seven Top analysts who recently rated the stock gave it their Buy recommendations. Taken together, their 12-month price target suggests a 504.65% upside potential.

Sable Offshore (SOC) – Sable is a Texas-based oil and gas company whose operations include offshore facilities off the coast of California and an onshore processing installation. Today, Roth MKM analyst Leo Mariani kicked off his coverage of the stock with a price target of $34 per share. This comes as all three Top analysts who evaluated the stock over the past three months rated it a Buy. Overall, their 12-month price target marks a 120.63% upside potential.

ACV Auctions (ACVA) – ACV, which is headquartered in Buffalo, New York, runs an online marketplace for wholesale vehicle auctions. Today, J.P. Morgan analyst Rajat Gupta reassessed ACVA stock and stuck to his price target of $18 per share. Notably, all seven Top analysts who recently reviewed this stock gave it a Buy rating. Across the board, their 12-month price target indicates a potential growth of 110.32% from the current level.

Who Are the Top Analysts? 

TipRanks ranks financial analysts based on the success rates of their ratings and the average return on each rating. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclaimer & DisclosureReport an Issue

1